Category: Licensing/Collaboration Deal Region: Asia · China Company: Innocare Pharma Ltd

InnoCare Announces First Prescription of Tafasitamab in Combination with Lenalidomide for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Under Boao Hope Citys Early Access Program

By, Admin 1 min read
Share
InnoCare Announces First Prescription of Tafasitamab in Combination with Lenalidomide for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Under Boao Hope Citys Early Access Program
InnoCare today announced that tafasitamab (Minjuvi

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!